Breaking News Instant updates and real-time market news.

AVP

Avon Products

$2.27

(0.00%)

, KIM

Kimco Realty

$14.26

(0.00%)

09:19
02/15/18
02/15
09:19
02/15/18
09:19

On The Fly: Pre-market Movers

UP AFTER EARNINGS: Avon Products (AVP), up 7.9%... Kimco Realty (KIM), up 3.4%... Cyberark (CYBR), up 2.5%... Huntington Ingalls (HII), up 2.9%... Aaron's (AAN), up 6.6%... Waste Management (WM), up 3.9%... Zoetis (ZTS), up 3.1%... Yandex (YNDX), up 6.7%... Precision Drilling (PDS), up 2.3%. ALSO HIGHER: Apple (AAPL), up 1.3% after Berkshire Hathaway and Appaloosa increase their stakes in the company. DOWN AFTER EARNINGS: TreeHouse Foods (THS), down 8.6%... Shopify (SHOP), down 3.9%... Global Payments (GPN), down 3.3%... Omnicom Group (OMC), down 5.2%... Commscope (COMM), down 1.3%... Hecla Mining (HL), down 2.2%.

AVP

Avon Products

$2.27

(0.00%)

KIM

Kimco Realty

$14.26

(0.00%)

CYBR

CyberArk

$45.35

0.67 (1.50%)

HII

Huntington Ingalls

$241.40

(0.00%)

AAN

Aaron's

$40.33

(0.00%)

WM

Waste Management

$82.60

(0.00%)

ZTS

Zoetis

$74.46

(0.00%)

YNDX

Yandex

$38.89

1.47 (3.93%)

PDS

Precision Drilling

$3.42

(0.00%)

AAPL

Apple

$167.37

3.03 (1.84%)

THS

TreeHouse

$43.01

(0.00%)

SHOP

Shopify

$137.56

(0.00%)

GPN

Global Payments

$107.58

(0.00%)

OMC

Omnicom

$82.78

(0.00%)

COMM

CommScope

$38.88

1.17 (3.10%)

HL

Hecla Mining

$4.02

(0.00%)

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 15

    Feb

  • 21

    Feb

  • 23

    Feb

  • 26

    Feb

  • 28

    Feb

  • 01

    Mar

  • 14

    Mar

  • 14

    Mar

  • 29

    Mar

AVP Avon Products
$2.27

(0.00%)

11/20/17
DADA
11/20/17
NO CHANGE
Target $2
DADA
Buy
Coty may consider acquiring Avon Products, says DA Davidson
DA Davidson analyst Linda Bolton Weiser speculates that Coty (COTY) may be interested in acquiring Avon Products (AVP). Weiser says Coty has recently added $587M in debt and when asked about it on the earnings call, it claimed it was related to Burberry license acquisition where the payment was only expected to be about $162M. Coty management has also hinted that it intends to grow its EPS by using its balance sheet, says the analyst in her research note. Weiser keeps her Buy rating and $2 price target on Avon, saying the company "represents one of very few ways to gain immediate entry to the Latin American beauty market" while also noting that Coty "raves" about direct-to-consumer sales models.
01/04/18
BOFA
01/04/18
DOWNGRADE
BOFA
Underperform
Avon Products downgraded to Underperform from Neutral at BofA/Merrill
11/07/17
DADA
11/07/17
NO CHANGE
Target $2
DADA
Neutral
Avon Products price target lowered to $2 from $3 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on Avon to $2 following the latest quarterly results. Weiser notes that along with the EPS miss, sales were flat and 100bp operating margin expansion model was too optimistic. The analyst notes that service disruptions and investments this year have offset cost reductions, while earthquakes in Mexico will likely weigh on Q4 earnings. The analyst is keeping her Neutral rating on Avon.
01/04/18
BOFA
01/04/18
DOWNGRADE
Target $2.5
BOFA
Underperform
Avon Products downgraded to Underperform at BofA/Merrill
As previously reported, BofA/Merrill downgraded Avon Products to Underperform from Neutral and lowered its price target to $2.50 from $3.50. Analyst Olivia Tong does not expect a quick rebound for Avon in 2018 following underwhelming 2017 results and sees continued risk to sales, margins, and cash flow.
KIM Kimco Realty
$14.26

(0.00%)

12/15/17
JPMS
12/15/17
DOWNGRADE
Target $20
JPMS
Neutral
Kimco Realty downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Anthony Paolone downgraded Kimco Realty to Neutral and lowered his price target for the shares to $20 from $22 in conjunction with his 2018 REIT outlook.
11/30/17
STFL
11/30/17
INITIATION
STFL
Hold
Kimco Realty resumed with a Hold at Stifel
Stifel resumed coverage of Kimco Realty with a Hold rating and $19.50 price target.
11/27/17
BARD
11/27/17
DOWNGRADE
Target $20
BARD
Neutral
Kimco Realty downgraded to Neutral from Outperform at Baird
Baird analyst RJ Milligan downgraded Kimco Realty to Neutral and lowered his price target for the shares to $20 from $23. To reflect increased disposition assumptions, the analyst lowered his 2018 FFO estimate for Kimco by 7% to $1.51. He finds it difficult to see how the shares outperform peers with $700M of development/redevelopment projects expected over the next two years.
09/26/17
JPMS
09/26/17
UPGRADE
Target $24
JPMS
Overweight
Kimco Realty upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Mueller upgraded Kimco Realty to Overweight with an unchanged price target of $24. Retail trends are beginning to improve and the shares trade at an attractive valuation, the analyst contends.
CYBR CyberArk
$45.35

0.67 (1.50%)

01/04/18
DBAB
01/04/18
NO CHANGE
Target $47
DBAB
Hold
Deutsche incrementally cautious on CyberArk after field discussions
Deutsche Bank analyst Gray Powell says he's incrementally cautious on CyberArk after speaking with a number of contacts in the privileged account management space. The analyst believes the bulk of the PAM market's growth going forward will be driven by mid-market companies that are more price sensitive than larger enterprises. Competition in this segment of the security software market is on the rise and CyberArk will increasingly compete against smaller vendors with cheaper solutions, Powell tells investors in a research note. He keeps a Hold rating on the shares with a $47 price target.
11/02/17
BOFA
11/02/17
UPGRADE
BOFA
Neutral
CyberArk upgraded to Neutral from Underperform at BofA/Merrill
09/21/17
JMPS
09/21/17
NO CHANGE
Target $53
JMPS
Outperform
CyberArk named a favorite pick after pullback at JMP Securities
JMP Securities analyst Erik Suppiger noted CyberArk shares have declined about 25% since it reported Q1 results in May after falling short of expectations in the past two quarters, though his recent checks give him confidence in demand and he thinks management has addressed some sales execution issues. Given the pullback and his positive channel checks, Suppiger sees the stock as a favorite name and reiterates his Outperform rating and $53 price target on CyberArk shares.
01/26/18
JMPS
01/26/18
NO CHANGE
JMPS
Fortinet, Proofpoint targets raised after positive checks at JMP Securities
JMP Securities analyst Erik Suppiger said his industry discussions lead him to believe the cyber-security spending environment has been relatively healthy and that security remains top of mind for enterprise buyers. Demand for internal security technologies that monitor and detect intrusions or technologies that add additional layers of security for specific assets is benefiting vendors such as CyberArk Software (CYBR), Proofpoint (PFPT), and Imperva (IMPV), Suppiger said. Given his positive channel checks and an appreciation in valuation multiples, Suppiger raised his price target on Proofpoint to $115 from $95 and on Fortinet (FTNT) to $54 from $41.
HII Huntington Ingalls
$241.40

(0.00%)

12/05/17
BERN
12/05/17
NO CHANGE
BERN
Defense earnings, free cash flow should benefit from tax reform, says Bernstein
Bernstein analyst Douglas Harned believes Defense earnings and free cash flow should benefit substantially in the near-term from Senate and House bills that lower the corporate tax rate from 35% to 20%, as large U.S. defense companies currently pay effective tax rates of 25%-30%. The analyst expects those effective rates to move to a 16%-20% range. Harned prefers Raytheon (RTN) among major U.S. defense contractors, based on international sales, but believes Huntington Ingalls (HII) should benefit most from tax reform and Lockheed Martin (LMT) least.
02/02/18
COWN
02/02/18
UPGRADE
COWN
Outperform
Huntington Ingalls upgraded to Outperform from Market Perform at Cowen
02/02/18
COWN
02/02/18
UPGRADE
Target $275
COWN
Outperform
Cowen calls Huntington Ingalls 'overlooked value,' upgrades to Outperform
Cowen analyst Gautam Khanna upgraded Huntington Ingalls to Outperform from Market Perform and raised his price target for the shares to $275 from $252. The shares are "excessively discounted" relative to the large cap defense peer average, Khanna tells investors in a research note. The analyst views Huntington as an "overlooked value" and believes sentiment on defense stocks is likely to remain strong given a funding uptick in the forthcoming fiscal 2019 defense budget request, lower corporate tax rates, and geopolitical tension.
02/02/18
02/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Hold at Argus with analyst Stephen Biggar saying the stock should trade above its historical average earnings multiple, with effective tax rate of 20% seen below 27% in 2017 as well as continued strong purchase volumes and growth in cross-border volumes and processed transactions. 2. Tableau (DATA) upgraded to Hold from Sell at Maxim with analyst Nehal Chokshi citing normalized bookings accelerating to 26% growth in the fourth quarter and sees normalized sales productivity stabilizing at about a 33% level. 3. Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale with analyst Warren Ackerman saying fourth quarter results were "solid" as emerging markets are rebounding strongly and the worst is over in North America. 4. Huntington Ingalls (HII) upgraded to Outperform from Market Perform at Cowen with analyst Gautam Khanna saying the shares are "excessively discounted" relative to the large cap defense peer average. 5. Sherwin-Williams (SHW) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying the Valspar deal adds another layer of potential growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AAN Aaron's
$40.33

(0.00%)

01/24/18
01/24/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI with analyst Duane Pfennigwerth citing the company's investor update. 2. Huntington Bancshares (HBAN) was downgraded to Neutral from Buy at Hilliard Lyons and to Neutral from Outperform at Macquarie. 3. Range Resources (RRC) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Evan Calio saying he expects oil markets to tighten and gas to remain weak in 2018. 4. CEVA downgraded to Perform from Outperform at Oppenheimer with analyst Andrew Uerkwitz downgraded Ceva (CEVA) to Perform from Outperform saying the valuation looks "full" at current levels. 5. Aaron's (AAN) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation rather than fundamentals, forecasting the company's core business to improve sequentially and also see benefits from the U.S. tax changes. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/24/18
LOOP
01/24/18
DOWNGRADE
Target $42
LOOP
Hold
Aaron's downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Anthony Chukumba downgraded Aaron's to Hold from Buy while keeping his $42 price target. Chukumba says the downgrade is based on valuation rather than fundamentals, forecasting the company's core business to improve sequentially and also see benefits from the U.S. tax changes. The analyst notes that after a recent run-up in the stock price, the current valuation is in line with his "relatively bullish fundamental outlook".
12/01/17
NRCS
12/01/17
NO CHANGE
Target $52.5
NRCS
Buy
Aaron's working to leverage Amazon traffic and mindshare, says Northcoast
Northcoast analyst Nick Mitchell said channel work indicates Aaron's (AAN) Progressive segment is working diligently to put together a scalable go-to-market strategy that would allow it to leverage Amazon's (AMZN) traffic and mindshare. The analyst believes Progressive's market leading position will translate into significant growth over the next 5 to 10 years and thinks Amazon could conservatively represent a $240M to $721M inventory outsourcing opportunity, or operating income in the range of $45M to $218M. Mitchell views this as another good reason to own the stock at these levels and reiterates his Buy rating and $52.50 price target on Aaron's.
11/29/17
SIDC
11/29/17
UPGRADE
Target $45
SIDC
Buy
Aaron's upgraded to Buy from Neutral at Sidoti
Sidoti analyst Brian Hollenden upgraded Aaron's to Buy saying the recent pullback in shares provides meaningful upside to his $45 price target.
WM Waste Management
$82.60

(0.00%)

01/03/18
MACQ
01/03/18
UPGRADE
MACQ
Outperform
Waste Management upgraded to Outperform from Neutral at Macquarie
01/03/18
MACQ
01/03/18
UPGRADE
Target $114
MACQ
Outperform
Waste Management upgraded to Outperform on strong cash flow at Macquarie
As previously reported, Macquarie upgraded Waste Management to Outperform from Neutral and raised its price target to $114 from $79. Analyst Hamzah Mazari expects a structurally higher free cash flow profile going forward driven by sustainable working capital improvement metrics, sees significant self help opportunities to bring customer churn down, higher than expected structural cash tax savings, and views valuation as attractive versus peers.
12/11/17
12/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. U.S. Steel (X) upgraded to Hold from Sell at Axiom with analyst Gordon Johnson saying he believes protectionism from the Trump administration and positive seasonality could create a "more optimistic tone" in the near-term. 2. Waste Management (WM) upgraded to Buy from Hold at Stifel with analyst Michael Hoffman saying he believes the company can embrace technology to improve customer experience, lower turnover, support better pricing, and improve productivity. 3. Air Products (APD) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he believes the industrial gases are positioned for a "classic late-cycle trade" amid improving industrial demand and a turn in the capex cycle. 4. DaVita (DVA) upgraded to Buy from Neutral at Citi with analyst Patrick Wood saying the sale of the company's DMG unit has resulted in an "unusual situation" where almost 40% of DaVita's current market capitalization is cash. 5. First Solar (FSLR) upgraded to Outperform from Neutral at Baird with analyst Ben Kallo citing its strong pipeline and balance sheet and continued cost and efficiency improvements. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/11/17
12/11/17
UPGRADE
Target $95

Buy
Waste Management upgraded to Buy, added to Select List at Stifel
As previously reported, Stifel analyst Michael Hoffman upgraded Waste Management to Buy from Hold, saying he believes the company can embrace technology to improve customer experience, lower turnover, support better pricing, and improve productivity. Hoffman, who also added the stock to the Stifel Analyst Select List and raised his price target on the shares to $95 from $80, also cited the company's organic growth, better free cash flow outlook and benefits from tax reform.
ZTS Zoetis
$74.46

(0.00%)

01/02/18
CHLM
01/02/18
NO CHANGE
Target $85
CHLM
Buy
Zoetis price target raised to $85 from $77 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for Zoetis to $85 from $77 as he believes colder temperatures instill confidence in sales of premium products and revenue projections. The analyst reiterates a Buy rating on the shares.
01/04/18
SBSH
01/04/18
UPGRADE
Target $85
SBSH
Buy
Zoetis upgraded to Buy from Neutral at Citi
Citi analyst Liav Abraham upgraded Zoetis (ZTS) to Buy and raised her price target for the shares to $85 from $67. The analyst "more constructive" on the Specialty Pharma group heading into 2018. More realistic expectations, along with pipeline catalysts set the stage for a potential inflection point for some of the stocks in 2018, Abraham tells investors in a research note on the sector. She expects continued commercial execution across Zoetis' portfolio and sees potential for continued topline growth in 2018. Mylan (MYL) is Abraham's top pick for 2018.
01/09/18
BMOC
01/09/18
NO CHANGE
Target $78
BMOC
Market Perform
Zoetis price target raised to $78 from $70 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Zoetis to $78, saying the lower corporate tax rate raises his FY18-21 net margin forecast by 2%-3% and EPS by 10%-11%. The analyst is positive on the company's "' fundamentals and solid execution", forecasting continued strong momentum for Zoetis in 2018. Arfaei also keeps his Market Perform rating on Zoetis, noting that the stock is "fairly valued", while the downside risks that include competitive price pressures may be underappreciated by the market.
01/18/18
PIPR
01/18/18
NO CHANGE
Target $86
PIPR
Overweight
Zoetis price target raised to $86 from $73 at Piper Jaffray
Piper Jaffray analyst Brett Wong raised his price target for Zoetis to $86 saying his firm's consumer survey supports U.S. companion animal growth. After an increase in 2017, the survey suggests almost 10% of respondents plan to increase the number of pets in their household in 2018, compared to just over 5% expecting to decrease, Wong tells investors in a research note. The analyst believes the trend of increasing pets per household remains a tailwind for Zoetis, and he still believes the underpenetrated dermatology market provides a "strong" growth opportunity. Wong keeps an Outperform rating on Zoetis.
YNDX Yandex
$38.89

1.47 (3.93%)

11/13/17
VTBC
11/13/17
UPGRADE
Target $40
VTBC
Buy
Follow-up: Yandex upgraded to Buy at VTB Capital
As previously reported, VTB Capital upgraded Yandex to Buy from Hold with a $40 price target. Analyst Vladimir Bespalov believes Yandex's ongoing investments into online advertising, taxi, and e-commerce are not fully reflected in valuation and views the recent correction in shares as an attractive entry-point.
11/13/17
VTBC
11/13/17
UPGRADE
VTBC
Buy
Yandex upgraded to Buy from Hold at VTB Capital
11/02/17
VTBC
11/02/17
DOWNGRADE
VTBC
Hold
Yandex downgraded to Hold from Buy at VTB Capital
01/16/18
DBAB
01/16/18
NO CHANGE
Target $50
DBAB
Buy
Yandex price target raised to $50 from $42 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Yandex to $50 saying he sees "meaningful upside" to the shares over the next three years as the ride share business scales and the company expands Uber Eats in Russia. Yandex Taxi alone could grow to $50 per share by 2023 in a "blue sky scenario," Walmsley tells investors in a research note. Today he values the Yandex pro forma ride share entity with Uber at $12 per share. The analyst reiterates a Buy rating on Yandex.
PDS Precision Drilling
$3.42

(0.00%)

11/07/17
SCOT
11/07/17
DOWNGRADE
SCOT
Underperform
Precision Drilling downgraded to Underperform from Sector Perform at Scotiabank
10/10/17
DBAB
10/10/17
INITIATION
DBAB
Hold
Precision Drilling initiated with a Hold at Deutsche Bank
Deutsche Bank analyst David Havens started Precision Drilling with a Hold rating and C$4 price target.
09/18/17
PIPR
09/18/17
UPGRADE
Target $4.25
PIPR
Overweight
Precision Drilling upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst John Daniel upgraded Precision Drilling to Overweight and raised his price target on the shares to $4.25 from $3.60. The analyst says Precision Drilling screens the most attractive in his firm's replacement value analysis.
11/08/17
JEFF
11/08/17
UPGRADE
Target $9
JEFF
Buy
Nabors Industries upgraded to Buy from Hold at Jefferies
Jefferies analyst Brad Handler upgraded Nabors Industries (NBR) to Buy citing visibility into free cash flow and earnings upside potential. The analyst raised his price target for the shares to $9 from $8. The analyst sees "incremental positives" for drillers including a path to activity and dayrate increases through 2018. His preference rank order within drilling is Patterson-UTI (PTEN), Precision Drilling (PDS), Nabors and Helmerich & Payne (HP).
AAPL Apple
$167.37

3.03 (1.84%)

02/15/18
MSCO
02/15/18
NO CHANGE
Target $203
MSCO
Overweight
iPhone X share gains accelerated in China in January, says Morgan Stanley
Morgan Stanley analyst Katy Huberty noted that Apple's 12% iPhone shipment growth in China last quarter was the company's second largest sequential share gain in China. According to smartphone data aggregating firm Jiguang, iPhone's overall active smartphone user share downticked in China in early January from recent highs, though iPhone X share gains accelerated in China during the month, Huberty tells investors. While acknowledging that iPhone is not seeing the "supercycle" she previously expected, Huberty still sees 4% total iPhone unit growth to 226M units estimated in FY18 and believes accelerating adoption of the highest end iPhone in China, the world's largest smartphone market, can drive active smartphone market share gains, she said. Huberty has an Overweight rating and $203 price target on Apple shares.
02/12/18
WELS
02/12/18
NO CHANGE
Target $195
WELS
Market Perform
Apple iPhone X was highest selling model, says Wells Fargo
Wells Fargo analyst Aaron Rakers notes that IDC has published its detailed estimates for smartphone shipments for the December quarter. The analyst thinks it is important to point out that, like Apple, IDC reports shipments on a sell-in less basis, with iPhone X shipments in the December quarter at 26.9M, which accounts for 35% of total shipments in Q4. Despite less than a full quarter of availability, iPhone X was the highest selling model in the September and December quarters, accounting for 22% of total shipments, he adds. Rakers reiterates a Market Perform rating and $195 price target on the shares.
02/13/18
02/13/18
NO CHANGE

AT&T the first carrier to offer BOGO deal for iPhone X, says Wells Fargo
Wells Fargo analyst Jennifer Fritzsche noted that AT&T (T) is the first cell phone carrier to offer a Buy One Get One Free, or BOGO, promotion on the Apple (AAPL) iPhone X, and highlighted that the deal has no requirement regarding new customers or trading in old devices. She said it is unclear if any other carrier will match the deal, although she noted that Verizon (VZ) and T-Mobile (TMUS) had attractive deals, although no true BOGO deal. Fritzsche also mentioned that AT&T has the "largest embedded base of iPhone users to protect," as it had iPhone exclusivity until 2011. Fritzsche has an Outperform rating and $48 price target on AT&T shares.
02/15/18
KEYB
02/15/18
NO CHANGE
KEYB
Apple iPhone inventories continue to pile up, says KeyBanc
KeyBanc analyst John Vinh says that despite generous promotions at carriers, he observed a significant spike in Apple (AAPL) iPhone days of inventory, and feedback indicates price point as the main reason why sales of the iPhone X has disappointed. Given elevated store inventory levels, Vinh sees limited near-term demand catalysts for Apple supply chain stocks. However, he views Apple initiatives to reduce cost as positive for Synaptics' (SYNA) CoF opportunity and would recommend investors continue to own the stock, as well as additional content plays moving forward, including Broadcom (AVGO) and Skyworks (SWKS).
THS TreeHouse
$43.01

(0.00%)

01/04/18
WELS
01/04/18
NO CHANGE
Target $46
WELS
Market Perform
TreeHouse price target raised to $46 from $41 at Wells Fargo
Wells Fargo analyst John Baumgartner raised his price target for TreeHouse to $46 from $41, citing tax reform and stronger macros. The analyst reiterates a Market Perform rating on the shares.
11/16/17
VERF
11/16/17
UPGRADE
VERF
Buy
TreeHouse upgraded to Buy from Hold at Vertical Group
12/04/17
WOLF
12/04/17
INITIATION
WOLF
Peer Perform
TreeHouse initiated with a Peer Perform at Wolfe Research
12/13/17
JPMS
12/13/17
NO CHANGE
Target $39
JPMS
Underweight
JPMorgan 'increasingly pessimistic' on TreeHouse's cash flow outlook
JPMorgan analyst Joshua Levine says he's "increasingly pessimistic" about the near-term free cash flow outlook for TreeHouse Foods. The analyst sees a "number of quantifiable drivers" that could cause the company's free cash flow to come in meaningfully below consensus in 2018 and 2019. He sees another potential leg down for the stock and keeps an Underweight rating on TreeHouse with a $39 price target.
SHOP Shopify
$137.56

(0.00%)

02/15/18
BARD
02/15/18
NO CHANGE
Target $110
BARD
Outperform
Shopify results suggest no change to positive thesis, says Baird
Baird analyst Colin Sebastian noted Shopify reported strong Q4 results and he saw nothing to indicate a change to his positive thesis. The analyst said profitability was better than expected and he believes the company's ability to execute in the face of increasingly difficult comps warrants a constructive look. Sebastian reiterated his Outperform rating and $110 price target on Shopify shares.
02/13/18
ROTH
02/13/18
NO CHANGE
Target $144
ROTH
Buy
Shopify price target raised to $144 from $127 at Roth Capital
Roth Capital analyst Darren Aftahi raised his price target for Shopify to $144 from $127 saying he anticipates Q4 results to be above expectations as his Q4 channel checks with the company's customers were again positive. The analyst looks for increased penetration on Plus and shipping products as benefitting MRR and GM's, and expects healthy guidance when it reports. Aftahi reiterates a Buy rating on the shares.
02/12/18
WEDB
02/12/18
NO CHANGE
Target $140
WEDB
Outperform
Shopify price target raised to $140 from $120 at Wedbush
Wedbush analyst Aaron Turner raised his price target for Shopify to $140 from $120 as he continues to view the stock as the top pick in his coverage and believes the company's momentum will continue for the foreseeable future. Further, the analyst believes Shopify is well-positioned to benefit from a long growth runway supported by significant and under-penetrated TAM, multiple growth vectors, and high-caliber managerial capability and execution. He reiterates an Outperform rating on the shares.
02/08/18
DADA
02/08/18
NO CHANGE
Target $110
DADA
Neutral
Shopify price target raised to $110 from $95 at DA Davidson
DA Davidson analyst Tom Forte raised his price target on Shopify to $110 ahead of Q4 earnings next week, saying the company's sales topped consensus in all 9 quarters reported since the company's IPO. Forte is positive on the company's platform "increasingly becoming a bigger part of the overall business" while also citing the management's view of a growing number of large merchants coming to Shopify from other platforms. The analyst keeps his Neutral rating, noting that the current share price reflects his favorable view of the company.
GPN Global Payments
$107.58

(0.00%)

12/04/17
DBAB
12/04/17
NO CHANGE
Target $82
DBAB
Buy
Vantiv price target raised to $82 from $72 at Deutsche Bank
Deutsche Bank analyst Bryan Keane raised his price target for Vantiv (VNTV) to $82 saying the company is well positioned over the medium term to capitalize on the secular shift toward e-commerce/omni-channel acquiring. Vantiv and Global Payments (GPN) are growing both integrated and e-commerce channels "strong double digits," Keane tells investors in a research note on Merchant Acquiring. He has a Buy rating on both names.
01/19/18
OPCO
01/19/18
NO CHANGE
Target $121
OPCO
Outperform
Global Payments price target raised to $121 from $110 at Oppenheimer
Oppenheimer analyst Glenn Greene raised his price target for Global Payments (GPN) to $121 saying he remains optimistic on the company's organic growth and margin opportunities. The analyst continues to like the merchant acquirer group, Global Payments, First Data (FDC) and Worldpay (WP) heading into 2018. He also raised his price target for First Data to $23 from $21 and for Worldpay to $85 from $77. Greene keeps Outperform ratings on all three names.
02/13/18
NOMU
02/13/18
NO CHANGE
Target $92
NOMU
Reduce
Global Payments price target raised to $92 from $85 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Global Payments to $92 ahead of the tomorrow's quarterly earnings report. He keeps a Reduce rating on the name. Deciphering the impact of Accounting Standards Codification 606 on fiscal 2018 growth will be critical as it could create a confluence of two conflicting forces, Dolev tells investors in a pre-earnings research note. Excluding 20%-25% of network fees from sales can drive a 1% drag to North America organic growth, but changing the timing of revenue recognition for certain software revenues can boost growth, the analyst writes. He's hopeful on Global Payments' transparency.
01/09/18
SPHN
01/09/18
UPGRADE
Target $122
SPHN
Overweight
Global Payments upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Brett Huff upgraded Global Payments to Overweight from Equal Weight, citing its top-tier organic revenue growth and best-in-class margin expansion. Huff raised his price target on Global Payments shares to $122 from $105.
OMC Omnicom
$82.78

(0.00%)

12/13/17
JEFF
12/13/17
DOWNGRADE
JEFF
Hold
Interpublic Group downgraded to Hold from Buy at Jefferies
Jefferies analyst John Janedis downgraded Interpublic Group (IPG) to Hold and lowered his price target for the shares to $20 from $24. The analyst believes the large U.S-based advertising agencies will continue to see "sub-trend" North America organic growth in 2018 due to competition, fee pressure, end market issues and work moving in-house. He also lowered his price target for Omnicom (OMC) to $72 from $82 and keeps a Hold rating on the shares.
01/25/18
BOFA
01/25/18
DOWNGRADE
BOFA
Underperform
Omnicom downgraded to Underperform from Neutral at BofA/Merrill
01/18/18
WELS
01/18/18
NO CHANGE
Target $75
WELS
Market Perform
Omnicom price target lowered to $75 from $81 at Wells Fargo
Wells Fargo analyst Peter Stabler lowered his price target for Omnicom to $75 from $81 as he expects pressures seen in 2017 to continue. The analyst reiterates a Market Perform rating on the shares.
01/02/18
MACQ
01/02/18
DOWNGRADE
MACQ
Underperform
Omnicom downgraded to Underperform from Neutral at Macquarie
COMM CommScope
$38.88

1.17 (3.10%)

01/11/18
SBSH
01/11/18
NO CHANGE
Target $45
SBSH
Buy
CommScope price target raised to $45 from $40 at Citi
Citi analyst Stanley Kovler raised his price target for CommScope to $45 saying the telco spending environment is improving ahead of 5G/spectrum deployments by carriers. In addition, tax reform should boost the company's earnings by 10%, Kovler tells investors in a research note. The analyst keeps a Buy rating on the shares.
02/14/18
LEHM
02/14/18
UPGRADE
Target $43
LEHM
Overweight
CommScope upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Amir Rozwadowski upgraded CommScope to Overweight and raised his price target for the shares to $43 from $42. The recent pullback in shares, coupled with data points suggesting an improving demand environment, suggests an attractive risk/reward for the company, Rozwadowski tells investors in a research note. He believes a focus on spectrum deployment and fiber builds should benefit the company on the back of rising U.S. carrier capex.
01/26/18
LBOW
01/26/18
UPGRADE
LBOW
Buy
CommScope upgraded to Buy from Neutral at Longbow
01/26/18
01/26/18
UPGRADE

Buy
CommScope upgraded to Buy on rising wireless spending at Longbow
As previously reported, Longbow upgraded CommScope to Buy from Neutral with a $45 price target. Analyst Shawn Harrison sees upside to CY18 North American wireless spending led by pull forward activity by AT&T, and to a lesser extent improved European growth forecasts, and upside if Sprint spends to plan.
HL Hecla Mining
$4.02

(0.00%)

11/17/17
BMOC
11/17/17
INITIATION
Target $4.75
BMOC
Market Perform
Hecla Mining initiated with a Market Perform at BMO Capital
BMO Capital analyst Ryan Thompson initiated Hecla Mining with a Market Perform rating and a $4.75 price target. Thompson says the company offers some of the "longest reserve lives" in the precious metal mining group, but valuation of price relative to Net Present Value is steep while the company's balance sheet is "weak".
11/30/17
RILY
11/30/17
UPGRADE
Target $5
RILY
Buy
Hecla Mining upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Lucas Pipes upgraded Hecla Mining to Buy with a $5 price target citing an attractive valuation and the company's Q3 performance.
12/04/17
CANT
12/04/17
INITIATION
Target $5
CANT
Overweight
Hecla Mining initiated with a Buy at Cantor Fitzgerald
Cantor Fitzgerald analyst Mike Kozak started Hecla Mining with a Buy rating and $5 price target. The analyst sees near term momentum from resolution of the strike at Lucky Friday and refinancing of the company's long-term debt. He believes both can happen in the first half of 2018.
11/14/17
11/14/17
UPGRADE
Target $5.25

Buy
Hecla Mining upgraded to Buy after post-earnings pullback at Canaccord
As previously reported, Canaccord analyst Dalton Baretto upgraded Hecla Mining (HL) to Buy from Hold, stating that he does not believe the selloff in the stock since the company's Q3 report is justified. Hecla reported strong production, but lower than expected revenue due to timing of shipments, which he expects to reverse next quarter, Baretto tells investors. The analyst, who also views the post-earnings selloff in Pan American Silver (PAAS) as overdone, now has Buy ratings on both miners. He has a $5.25 price target on Hecla and a $23 price target on Pan American.

TODAY'S FREE FLY STORIES

03:05
12/17/18
12/17
03:05
12/17/18
03:05
General news
FX Update: Narrow ranges have prevailed »

FX Update: Narrow ranges…

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated at Gabelli »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change at Stifel »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change at Goldman Sachs »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change at Goldman Sachs »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.